About depemokimab
Interleukin-5 pathway monoclonal antibody
Used for
- Add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents.
- Add-on treatment for chronic rhinosinusitis with nasal polyps in adults.
Usual adult dose
Usual dose: 100 mg by subcutaneous injection every 6 months.
Common side effects
- Injection-site reactions
- Headache
- Joint pain
- Back pain
Important warnings
- Not for treating sudden asthma attacks or acute worsening.
- Severe allergic reactions can occur.
- Treat existing parasitic infections before starting; seek treatment if infection develops.
- Do not stop inhaled or other asthma medicines abruptly.
Pregnancy
Human pregnancy information is limited; use only when potential benefits justify potential risks.
Breastfeeding
Information is limited; discuss potential risks and benefits with a healthcare professional.
Interactions
- No clinically important drug interactions are currently established.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.